Jaguar Health, Inc. 8-K

What Happened Jaguar Health, Inc. announced on June 22, 2026 (Form 8-K, Item 7.01 - Regulation FD Disclosure) that its Board of Directors has decided to initiate a process to explore and review a range of strategic alternatives aimed at maximizing shareholder value, following an evaluation of current market conditions. The company furnished a press release dated June 22, 2026 as Exhibit 99.1 to the filing.

Key Details

• Filing date: June 22, 2026 (8-K, Item 7.01, Regulation FD Disclosure).
• Board action: Initiated a review process to explore and review a range of strategic alternatives focused on maximizing shareholder value.
• Supporting material: Press release dated June 22, 2026 furnished as Exhibit 99.1.
• Company did not disclose specific transaction types, timelines, financial terms, or outcomes in the filing.

Why It Matters This notice formally informs investors that Jaguar Health’s board is actively evaluating strategic options in response to market conditions. While the filing does not provide details on any specific transaction, timing, or expected financial impact, investors should watch for future filings or press releases for updates that could affect the company’s strategy, ownership structure, or valuation.